Articles & guides — page 7
125 cited, vendor-independent pieces on the questions people actually ask — reconstitution and handling, half-lives, compound comparisons, and how to track a protocol. Research and education only; never dosing advice, never sourcing.
125 articles
What is maritide?
Maritide (maridebart cafraglutide / AMG 133) explained: the GIPR-antagonist + GLP-1-agonist conjugate, the GIP paradox versus tirzepatide, its phase-1 results, monthly dosing, and its status.
Human clinical dataCompound overviews4 minWhat is amycretin?
Amycretin explained: the single-molecule GLP-1 and amylin receptor co-agonist, its oral and injectable forms, the striking early weight-loss numbers, and its status as an investigational drug.
Human clinical dataCompound overviews6 minWhat is Semax?
Semax explained: the Russian ACTH(4-10) nootropic peptide that raises BDNF, studied intranasally for stroke — and why nearly all its human data is Russian.
Human clinical dataCompound overviews6 minWhat is Selank?
Selank explained: the Russian tuftsin-analog anxiolytic peptide that modulates GABA and serotonin — and why its human evidence is small and mostly Russian.
Human clinical dataCompound overviews5 minWhat is Epithalon (Epitalon)?
Epithalon (Epitalon) explained honestly: the synthetic pineal tetrapeptide studied for telomerase and longevity, and why nearly all its evidence is preclinical and from one Russian group.
PreclinicalCompound overviews4 minWhat is MOTS-c?
MOTS-c explained with the science: a mitochondrial-derived peptide studied as an exercise mimetic for metabolism and aging, and why almost all the strong evidence is from mice and cells.
PreclinicalCompound overviews5 minWhat is Thymosin Alpha-1 (Zadaxin)?
Thymosin Alpha-1 (Zadaxin) explained: a 28-amino-acid immune-modulating peptide with real human trials in hepatitis, sepsis and cancer, and approved as a medicine in dozens of countries.
Human clinical dataCompound overviews4 minWhat is KPV?
KPV explained: the three-amino-acid tail of the hormone alpha-MSH studied as an anti-inflammatory for gut and skin, and why its evidence is preclinical, from colitis mouse and cell models.
PreclinicalCompound overviews5 minWhat is survodutide?
Survodutide explained plainly: the investigational GLP-1 / glucagon dual agonist, its phase-2 obesity and MASH results, and why it stays investigational.
Human clinical dataCompound overviews5 minWhat is mazdutide?
Mazdutide explained plainly: the investigational GLP-1 / glucagon dual agonist behind the GLORY-1 and GLORY-2 China phase-3 trials, and its weight-loss data.
Human clinical dataCompound overviews5 minWhat is CagriSema?
CagriSema explained plainly: cagrilintide (an amylin drug) plus semaglutide, what the phase-3 REDEFINE trials showed, and how it compares with tirzepatide.
Human clinical dataCompound overviews5 minWhat is liraglutide?
Liraglutide explained plainly: the older once-daily GLP-1 drug (Saxenda / Victoza), why its short half-life means daily dosing, and its SCALE and LEADER trials.
Approved medicineZyra Track is a research and educational utility. Nothing on this page is medical advice, a dosing recommendation, or an endorsement of any compound. We never sell or source compounds and refuse sourcing questions. Consult a qualified clinician for decisions about your health.